Literature DB >> 18025453

Pegvisomant-induced lipohypertrophy: report of a case with histopathology.

Monica Marazuela, Esteban Daudén, Elena Ocón, Dolores Moure, Lia Nattero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18025453     DOI： 10.7326/0003-4819-147-10-200711200-00019

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

Review 1.  Lipodystrophy during pegvisomant therapy: a case report and review of the literature.

Authors:  D Buyuktas; O Celik; F Kantarci; P Kadioglu
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

2.  Self-limited acute hepatotoxicity caused by pegvisomant.

Authors:  A Soto Moreno; R Guerrero Vázquez; E Venegas Moreno; S Palma Milla; J P Castaño; A Leal Cerro
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

3.  Clinical and radiological evidence of the recurrence of reversible pegvisomant-related lipohypertrophy at the new site of injection in two women with acromegaly: a case series.

Authors:  Vincenzo Rochira; Lucia Zirilli; Chiara Diazzi; Stefania Romano; Cesare Carani
Journal:  J Med Case Rep       Date:  2012-01-10

4.  A Child with Local Lipohypertrophy following Recombinant Human Growth Hormone Administration.

Authors:  Ilan J N Koppen; Roel Bakx; Chris C de Kruiff; A S Paul van Trotsenburg
Journal:  Case Rep Pediatr       Date:  2016-10-10

Review 5.  Pegvisomant in acromegaly: an update.

Authors:  A Giustina; G Arnaldi; F Bogazzi; S Cannavò; A Colao; L De Marinis; E De Menis; E Degli Uberti; F Giorgino; S Grottoli; A G Lania; P Maffei; R Pivonello; E Ghigo
Journal:  J Endocrinol Invest       Date:  2017-02-07       Impact factor: 4.256

6.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

7.  Body Composition Changes with Long-term Pegvisomant Therapy of Acromegaly.

Authors:  Adriana P Kuker; Wei Shen; Zhezhen Jin; Simran Singh; Jun Chen; Jeffrey N Bruce; Pamela U Freda
Journal:  J Endocr Soc       Date:  2021-02-01

Review 8.  Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?

Authors:  Sandro Gentile; Felice Strollo; Antonio Ceriello
Journal:  Diabetes Ther       Date:  2016-07-25       Impact factor: 2.945
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.